{
    "clinical_study": {
        "@rank": "136279", 
        "arm_group": [
            {
                "arm_group_label": "Normal eyes", 
                "description": "Eyes without pathology."
            }, 
            {
                "arm_group_label": "Glaucoma", 
                "description": "Eyes with Glaucoma."
            }, 
            {
                "arm_group_label": "Retinal", 
                "description": "Eyes with Retinal Disease."
            }, 
            {
                "arm_group_label": "Corneal", 
                "description": "Eyes with corneal disease including a kerato-refractive group."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to asses the agreement of the RS-3000 Lite and RS-3000 Advance\n      to the RS-3000, assess the crossed precision of each study device and to assess the\n      transference of a reference database from the RS-3000 to the RS-3000 Lite and to the RS-3000\n      Advance."
        }, 
        "brief_title": "OCT Agreement and Crossed Precision Study", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Glaucoma", 
            "Retinal Disease", 
            "Corneal Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Corneal Diseases", 
                "Glaucoma", 
                "Retinal Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: NORMAL EYES\n\n          -  Subjects who do not have pathology in both eyes\n\n        Inclusion Criteria: GLAUCOMA\n\n          -  Subjects who have a glaucoma diagnosis\n\n        Inclusion Criteria: RETINAL\n\n          -  Subjects who have a retinal diagnosis including but not limited to:\n\n               1. Diabetic macular edema\n\n               2. Dry age related macular degeneration\n\n               3. Wet age related macular degeneration\n\n               4. Cystoid macular edema\n\n               5. Epiretinal membrane\n\n               6. Macular hole\n\n        Inclusion Criteria: CORNEAL\n\n          -  Subjects who has one of these diagnosis:\n\n               1. Post status LASIK surgery\n\n               2. Keratoconus\n\n               3. Other corneal dystrophies or degenerations.\n\n        Exclusion Criteria: ALL EYES\n\n          -  Subjects who have any of the following conditions\n\n               1. Diabetes mellitus (DM) and/or diabetic retinopathy\n\n               2. Uncontrolled Hypertension (HT)\n\n               3. Cerebral infarction, cerebral hemorrhage, cranial nerve neoplasm and other\n                  central nervous system diseases affecting vision\n\n               4. Cardiac, hepatic, renal and hematologic diseases\n\n               5. A current condition requiring systemic administration of steroid\n\n               6. A history of, or currently receiving, anticancer therapy\n\n               7. Epileptic seizures which are optically induced\n\n               8. Dementia\n\n          -  Subjects who have other life threatening and debilitating systemic diseases\n\n        Note:  Additional criteria may apply"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Clinic subjects, general population"
            }
        }, 
        "enrollment": {
            "#text": "168", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02050880", 
            "org_study_id": "RS-3000 series Protocol 1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Normal Eyes", 
            "Eye; Disorder with Glaucoma", 
            "Eye; Disorder with Retinal Disease", 
            "Eye; Disorder Corneal Disease incl kerato-refractive group"
        ], 
        "lastchanged_date": "January 30, 2014", 
        "location": {
            "contact": {
                "email": "Johnny.Leng@wcct.com", 
                "last_name": "Johnny Leng", 
                "phone": "312-925-0906"
            }, 
            "facility": {
                "address": {
                    "city": "Santa Ana", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "92705"
                }, 
                "name": "WCCT Global Opthalmology Research Center"
            }, 
            "investigator": {
                "last_name": "Michael Sheety, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "4", 
        "official_title": "Crossed Precision Design Study of the Nidek Optical Coherence Tomography RS-3000, RS-3000 Lite and RS-3000 Advance for the Measurements of Retinal and RNFL Thickness, Optic Disc Analysis, and Pachymetry", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Time frame is the maximum duration of hospital stay", 
                "measure": "Retinal thickness", 
                "safety_issue": "No", 
                "time_frame": "Approximately four hours"
            }, 
            {
                "description": "Time frame is the maximum duration of hospital stay", 
                "measure": "Optic Disc Analysis", 
                "safety_issue": "No", 
                "time_frame": "Approximately four hours"
            }, 
            {
                "description": "Time frame is the maximum duration of hospital stay", 
                "measure": "Corneal Thickness", 
                "safety_issue": "No", 
                "time_frame": "Approximately four hours"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02050880"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Nidek Co. LTD.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nidek Co. LTD.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}